Experts are predicting COVID cases in China will explode after the country ended its strict zero-COVID policy. Here’s how the US may be affected.
Author: Karen Weintraub, USA TODAY
As COVID cases rise, White House announces more prevention efforts, including free tests
More free at-home COVID tests are part of the White House’s plan to combat rising cases this winter season.
America has a pain problem. How can we find relief?
To better understand America’s pain problem and what to do about it, USA TODAY spoke with more than 50 pain experts and people with chronic pain.
NFL players age faster than the rest of us. Harvard is researching what can be done.
A Harvard study finds NFL players age a decade faster than the general population and are suffering young from arthritis and high blood pressure.
Weight loss treatment is on the verge of transformation. It’s not there yet. Here’s why.
New anti-obesity medicines like Wegovy promise dramatic weight loss, but there’s a long way to go to make them accessible to those who need them.
Where did mpox go? Here’s what brought down cases of disease formerly known as monkeypox.
Cases of the disease formerly known as monkeypox are down as the Biden administration declares an end to the public health emergency.
Thousands of babies and children are hospitalized by RSV every year. Why that could soon change.
Six drug companies are now developing RSV vaccines or antibodies, suggesting this year could be the last without adequate tools to fight the virus.
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.
The Food and Drug Administration on Thursday approved the use of Relyvrio to treat amyotrophic lateral sclerosis, more commonly known as ALS.
‘Food as medicine’: White House pilot program would bring medically tailored meals under Medicare
Medically tailored meals are one of many new programs proposed Tuesday by the Biden administration to reduce hunger and diet-related diseases.
FDA authorizes reformulated COVID-19 booster shot for the fall
The new booster shots could be available within days, after a CDC committee on Thursday recommends who should get them and its director signs off.